CEO of the leading medical firm Pfizer, Albert Bourla, announced on Tuesday that the company can deliver 10% more COVID-19 vaccine doses to the US in May; increasing the total number of vaccine doses to 220 million instead of 200 doses.
In a tweet, he added that the company "ramped up" its production of the Pfizer vaccine to deliver 300 million doses to the US by the end of July.
After the latest increase in vaccine production, the firm can supply the US with the doses two weeks earlier than the previously scheduled date, according to Bourla.
This tweet came after the federal health authorities suspended the use of Johnson&Johnson (J&J) after receiving advice from the Food and Drug Administration (FDA) after reporting a number of rare brain blood clotting cases in six women.
Moreover, FDA announced on Tuesday that 1 dead, and another in critical condition after receiving the J&J vaccine jab.
Many states decided to replace the J&J shots with Pfizer to continue the vaccination rollout in the US amid Biden's promise of giving the Americans 100 million vaccines during his first 100 days in the office.